A Win for Small–Cell Lung Cancer: IMPOWER 133

0 Views
administrator
administrator
07/14/23

An expert panel comments on the positive results of the IMpower 133 trials, which evaluated the use of carboplatin, etoposide, and atezolizumab in extensive-stage small–cell lung cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next